Table 4.
Scenario analysis results with wastage consideration.
| Treatment sequence | Cost | Incr Cost | QALY | Incr QALY | Incr C/E | NMB |
|||
|---|---|---|---|---|---|---|---|---|---|
| ℷ = 50,000 | ℷ = 100,000 | ℷ = 150,000 | ℷ = 200,000 | ||||||
| All referencing common baseline | |||||||||
| 3rd | 67,128.18 | 1.275 | −3395.37 | 60,337.45 | 124,070.26 | 187,803.07 | |||
| 4th | 76,487.72 | 9359.55 | 1.407 | 0.132 | 70,896.37 | −2758.68 | 3842.18 | 10,443.05 | 17,043.91 |
| 2nd | 147,559.6 | 80,431.45 | 1.781 | 0.506 | 158,961.4 | −55,132.39 | −29,833.34 | −4534.28 | 20,764.77 |
| 1st | 149,759 | 82,630.86 | 1.808 | 0.534 | 154,848.9 | −55,949.73 | −29,268.59 | −2587.46 | 24,093.67 |
Abbreviations: C/E, cost-effectiveness; Incr, incremental; NMB, net-monetary benefit; QALY, quality-adjusted life year.